, but it was not until 1926 that the first cases in England were described by members of the factory medical inspectorate (Bridge, 1927) . The first contribution from the industry itself came from Wignall in 1929 Medical Inspector of Factories, reported that 28 deaths from occupational bladder tumours had come to his notice. Goldblatt (1949) described 101 cases from a group of British factories and Scott (1952) recorded 66 cases from yet another works.
In 1947 the Dyestuffs Group of the Association of British Chemical Manufacturers (A.B.C.M.) set up and financed a major research project on industrial papilloma of the bladder. This has been described in a booklet which was circulated to managements, trades unions, and workmen (1953) .
A scientific committee was appointed under the chairmanship of Professor A. Haddow to guide research work into the cause, consider diagnostic methods, and examine preventive techniques. A sub-committee was invited, under the chairmanship of Mr. N. Strafford, to provide accurate methods for the analysis of suspected compounds under industrial conditions (Butt and Strafford, 1956 ). In 1948 a research fellow, Dr. R. A. M. Case, was appointed at the Chester Beatty Institute to conduct an investigation into the industrial data. This enquiry covered the records of over 30 years of the manufacture of dyestuffs and their intermediates in Great Britain. The results and the statistical analysis were published in 1954 (Case, Hosker, McDonald, and Pearson, 1954) .
Case and his co-workers were able to produce statistical proof that contact with alpha-naphthylamine, beta-naphthylamine and benzidine, three compounds which had previously been suspected, caused a significant incidence of bladder tumour amongst the men engaged in their manufacture or use. No evidence was found to inculpate aniline and it is now considered that under the conditions of its manufacture and use in this country it is not a significant cause of bladder tumour, and that the name aniline cancer of the bladder is an unfortunate misnomer. Suspicion, however, fell on the manufacture of magenta and auramine and further data collected and analysed confirmed that the risk also existed in connexion with their manufacture. The results of the study were at once given to the Ministry of Pensions and National Insurance, and in 1953 papilloma of the bladder was prescribed as an industrial disease in occupations involving contact with alpha-naphthylamine, beta-naphthylamine, or benzidine, and the manufacture of auramine or magenta. Progress had already been made in many directions to improve the methods of protection from the compounds now proved to be carcinogenic, but it was obviously necessary not only to devise the safest possible method of working but also to be able to assess the efficacy of those measures in eradicating the tumours. We were, therefore, invited by the A.B.C. M. to draw up a " code of industrial practice" to cover the manufacture and use of known or suspected bladder carcinogens and the present paper is based on (Macalpine, 1947) . There is no demonstrable difference between those contracted by chemical workers and those arising in the general population.
Recurrences are frequent and tumours may recur as papillomata or as carcinomata irrespective of the nature of the original lesion. It is thought that many of these so-called recurrences are fresh tumours arising in an already activated bladder mucosa. The usual complications, such as haemorrhage and infections, occur with either type of tumour.
The onset is insidious and the disease may be advanced or even incurable before any symptoms or signs appear, but, on the other hand, it is common for severe symptoms to occur in the early stages when treatment is likely to effect a cure. Usually, the first sign is haematuria, but bleeding may not be visible even in advanced disease. Another sign is pyuria caused by the tumour surface ulcerating or becoming infected. Other signs or symptoms such as dysuria or frequency may arise, depending on the stage to which the tumour or its complications has advanced. It will be obvious from this that any haematuria, even in microscopic amounts, must be regarded with suspicion and this is extremely important in early diagnosis.
Because of the tendency to recurrence, it follows that once a tumour has been treated it is necessary to have regular follow-up examinations and review of each case at suitable intervals. Even when apparent cure has been maintained over many years at least annual re-examination should be continued. In view of the long latent period, in some cases over 30 years, it also follows that once a man has been exposed for a sufficient time to chemicals which can cause bladder cancer he remains at risk for the rest of his life, whether he continues to work with them or not. We consider that a period of six months' exposure can be sufficiently long but even shorter periods may come to be accepted as sufficient to induce a tumour.
PART I Medical Recommendations
This section deals with the medical control of the hazard, with selection and education of workers, the methods of protection, and the keeping of records. Our recommendations for ensuring the early diagnosis of tumours in industrial workers at risk are the subject of a separate paper (Crabbe, Cresdee, Scott, and Williams, 1956) , which should be studied in conjunction with these recommendations.
Medical Control.-Medical control is essential to ensure (1) proper selection and adequate medical supervision of workers; (2) early diagnosis of bladder tumours; (3) liaison with the family doctor, the urologist, and the hospital; (4) the follow-up of men with established tumours from the point of view of their treatment, regular reviews, and working capacity; (5) Protective Measures.-In industry these compounds enter the body by two main routes-inhalation and absorption through the skin-but it should be borne in mind that they can also be ingested. Thus the aim of all preventive measures must be to reduce to the minimum, and where possible to eliminate, all contacts between operator and carcinogens. The first and basic method of ensuring this end must be by plant design and operation. The second line of defence is the provision of personal protection for the workmen but the hygiene of the plant and of the working environment is more important than any measure which depends for its efficiency on the cooperation or discipline of the operator or on any measure which is under his control (Legge, 1934) .
Working Clothing.-No man should wear any of his own clothing while exposed to carcinogens. A complete set of working clothing should be supplied and should include underwear, footwear, socks, and outer-wear. They should be changed immediately on accidental contamination, and should be changed and washed at regular intervals depending on the plant conditions and on the degree of exposure but not less than once a week in any circumstances. A daily change will avoid the absorption of amine which has impregnated the clothing on the previous day. For laundering a slightly acid synthetic detergent is preferable to alkaline soap as the latter leads to the formation of the insoluble base which may dry in the clothes. The clothing should be tested at frequent intervals for the presence of amines by the methods which have been described by Butt and Strafford (1956) . This forms a useful check on the efficacy of the measures taken to prevent absorption of the noxious substances. The working clothing supplied should be taken off at the end of each shift and must be left at the factory. On no account should it be taken home. Separate lockers should be provided for home and working clothes so that no cross contamination takes place. A clean smock or coat can be worn during meals so that tables and food are not contaminated from working clothes.
Protective Clothing.-The protective clothing, which should be supplied and worn in addition to the working clothing described above, will vary according to the process and the type of plant and the resultant potential exposure, but will generally consist of overalls of closely woven cotton or wool (or blouse and trousers of similar material), rubber boots, rubber or plastic gloves with gauntlet fitting or long sleeves attached, and a cap which can be washed.
GLovEs. Baths.-Suitable changing and bathing facilities with adequate hot water, soap, and towels must be available at the factory. Shower baths are the most satisfactory and are usually preferred, but some workers, especially the older ones, prefer a slipper bath. The main objection to the slipper bath is that in cases of contamination some amine may remain on the skin from the bath water; there may also be some danger of inhaling amine volatilized by the hot water while lying in the bath.
(1) A bath or shower must be taken at the end of each shift so that small quantities of amine which may be present on the skin will be removed. This must be obligatory and the bathing time should be paid for. Twenty minutes is regarded as adequate time.
(2) These compounds can be absorbed directly through the skin in any physical form as Having discussed the basic principles to be adopted in considering the elimination of this hazard from the dyestuffs industry, it is now proposed to devote a section to each relevant process. These sections may repeat some of the general principles but it is intended to point out to the manufacturer the main and also the subtle dangers associated with the operation of each process. Explanations based on experience of factory conditions are included where necessary as well as any relevant results of animal experiments.
Beta-naphthylamine
The manufacture of beta-naphthylamine has proved to be by far the most hazardous occupation in the dyestuffs industry. It was felt that no plant could be economically devised which could be operated with any degree of certainty that tumours would not occur. The cessation of its manufacture and use in 1952 in Great Britain is considered to be one of the most important measures in the prevention of industrial bladder tumours.
Its main use was in colour manufacture for which beta-naphthylamine was sulphonated. The sulphonated compounds, which are not considered to be carcinogenic, can be made effectively by the amination of the appropriate sulphonated betanaphthols.
The use of beta-naphthylamine to make rubber chemicals and colours has also been abandoned in Great Britain. In the case of the rubber chemicals and small colour manufacturers, alternative products with similar or improved technical effects have been developed using non-carcinogenic intermediates.
Tobias Acid (2 Naphthylamine-l-Sulphomic Acid)
Since crude and technical Tobias acid contain a trace of beta-naphthylamine as an impurity, this compound must be treated with certain precautions. This impurity can be reduced to a minimum by appropriate control of process conditions. The beta-naphthylamine is present as the sulphate so that no free amine is volatilized during drying. However, the final dry powder may constitute a potential hazard, both in manufacture and use.
Efficient draughting should be provided at the packaging point and a type of enclosed drier is recommended as opposed to any form of tray drying. The product is very apt to " fly " and it is doubtful if tray drying can be achieved with complete safety.
Full protective clothing for the workman with dust masks or fresh-air hoods should be adequate for charging this powder for use in subsequent processes, but pneumatic handling is preferable if large amounts are regularly used. Anti-dusting treatment of the powder should not be relied upon.
No tumours have been attributed to Tobias acid manufacture in any country to date, but in view of the vast increase in manufacture accompanying the cessation of beta-naphthylamine manufacture, exposure to it will certainly be increased greatly and the recommended precautions must be taken.
Benzidine
The findings of Case et al. (1954) removed any doubt previously held as to the hazard associated with the manufacture of this chemical. No alternative has been found, however, to the use of benzidine in colour manufacture as has been the case with beta-naphthylamine. The hazard is believed to exist after the conversion of hydrazobenzene to benzidine. In some factories, where the reduction of nitrobenzene to hydrazobenzene and the subsequent conversion to benzidine have been entirely separated, no tumours have been recorded amongst men carrying out the reduction process, whilst many tumours have occurred amongst those working on the conversion and isolation of benzidine itself. However, in many cases reduction and conversion are carried on in the same building and, therefore, full-scale precautions are recommended for both. Whether the reduction is effected by zinc dust, sodium amalgam, or electrolytic means, enclosure of all plant items should be aimed at. If it is necessary to isolate the hydrazo compound, enclosed types of filter should be used. The conversion vessel should be totally enclosed and dip pot sampling should be avoided. The material should be handled in an enclosed system as a slurry before isolation in an enclosed filter. The distillation of benzidine base and the isolation of the product in solid form as base is liable to result in contamination of the atmosphere with vapour which can be entirely avoided by final isolation as a salt. The final product must be packed with all necessary precautions against dust and skin contact. The salts of benzidine can be absorbed easily through the skin and no refuge must be sought in the suggestion that the salts are less dangerous. Tumours have occurred amongst men handling all the salts and the base in various factories in the world. Isolation of benzidine as salt, however, avoids almost completely the possibility of vapour contamination but a potential dust and skin hazard still exists.
The isolation of this compound from an open nutsche filter press or any open filter device is dangerous. In the event of the product being manufactured as base, the grinding of the final product as opposed to flaking is strongly deprecated. The best conditions are most likely to be attained with the isolation of the final product as a salt paste but the whizzing of base in an enclosed centrifuge can be performed safely. Special attention must be paid to the provision of protective clothing to the workman lidding drums in this manufacture. If attempts to isolate a very dry paste are made, a dust hazard immediately arises and a user hazard is also created as the packages are difficult to empty safely.
Benzidine Azo Colours Tumours have occurred amongst a number of men manufacturing azo colours from benzidine. It is interesting and important to note that these benzidine azo colours are the only ones using carcinogenic intermediates made continuously throughout the year. The incidence of tumours amongst azo process men is largely confined to the manufacture of these large-scale benzidine colours. This would result in these particular workmen getting a considerably higher total dose of carcinogen than those employed for short and occasional periods on other work using carcinogens as intermediates.
If benzidine itself is manufactured in a user factory, then there is no doubt that bulk handling of an amine slurry or tetrazo solution is to be preferred to filling and emptying containers. In emptying a package with a shovel in azo manufacture there is no doubt that the clothing will become contaminated. In the case of smaller manufactures where handling drums or casks is inevitable an automatic device can be installed which will wash out the benzidine from the container by high pressure cold water. This can be operated quite safely and the water is used to make the solution for the subsequent tetrazo reaction. It may prove most effective to charge all the benzidine used in an azo shed to one well-protected point using such a device. Subsequently, slurry or tetrazo solution can be pumped to different units as is advocated in the case of factories where benzidine is manufactured within the same works. Great care will be necessary in obtaining samples from such a central source for assessment of the strength of the slurry. An automatic enclosed device should be installed for obtaining such samples without using a dip tin which would drip on the surrounding floor and perhaps splash the man taking the sample. It is not recommended that batch weights of benzidine should be made up but if this has to be done, full-scale impervious clothing must be worn together with a fresh-air hood.
Tests for residual benzidine in the final product should be made to avoid atmospheric contamination during its drying or grinding.
o-Tolidine, Dianisidine, and Dichlorbenzidine Although animal experiments on the rat suggest that the homologues and derivatives of benzidine are considerably less carcinogenic than the parent amine, it is felt that in industrial practice the homologues should be treated in a similar fashion to benzidine itself if large amounts are handled. Whereas there are records ofmen developing tumours who have been exposed to benzidine without its homologues, no population is known which has been exposed to the homologues of benzidine without the parent amine also being manufactured in the same plant.
Thus, in the manufacture of azo colours from o-tolidine, dianisidine, dichlorbenzidine, or benzidine disulphonic acid, an emptying device employing high-pressure water jets should be used for charging these intermediates to the azo vats. Benzidine disulphonic acid is not believed to be a carcinogen.
The final colour should be analyzed to ensure that no free amine is volatilized during drying.
Alpha-naphthylamine
The manufacture of alpha-naphthylamine has been associated with an incidence of tumours of the bladder amongst workers employed on it under poor conditions where very heavy exposure was encountered. Even under these conditions, exposure of five years or more was necessary for a tumour to develop. Statistical evidence suggests that it is of considerably lower potency than benzidine or beta-naphthylamine as a carcinogen in man. The commercial product usually contains about 4% beta-isomer but this level may be higher in some cases. Hazards exist during reduction of alphanitro-naphthalene and distillation and isolation of the final product. Completely enclosed plant should be used for the reduction with special attention paid to the gland of the agitator shaft. Any residue should be transferred through an enclosed system to a vessel where the amine can be completely destroyed. Special devices should be used for obtaining samples in order to ascertain the state of the reduction and the use of a dip pot for obtaining such samples is strongly deprecated. Where large quantities of material are to be handled by the user the final product should be transferred molten in tankers but some flaking will be necessary for the smaller user. The flaker should be totally enclosed and draughted. Attention to the flaking conditions can increase the size of flake and reduce the amount of fine dust in the final product.
Alpha-naphthylamine Sulphate This manufacture carries with it not only the risk in the charging of the initial amine, but also the risk of handling the final product. Thus, the charging point should be adequately ventilated to avoid contamination of the general atmosphere with dust or the material can be handled molten in an enclosed system to avoid this hazard completely. The hazard in the filtration and drying of this product is one of skin contact and inspiration of dust. During the drying, vapour will not be given off but dust will collect in the vents from the drying space. A continuous enclosed drier is recommended and the use of any form of tray drying is strongly deprecated.
Alpha-naphthol Although this chemical is made from alphanaphthylamine it is not believed to be carcinogenic. Bulk use of molten alpha-naphthylamine in a totally enclosed system to avoid atmospheric contamination is recommended. Analytical estimations of alpha-naphthylamine in the final product should be maintained to ensure its safety.
Naphthionic Acid There is no evidence to suggest that naphthionic acid itself is carcinogenic but its manufacture involves the handling of alpha-naphthylamine. The amine charging point is the first hazard. In the event of a bulk supply of molten alphanaphthylamine being available, heated enclosed measure vessels and weigh-scales can be used so that no problem of charging solid alpha-naphthylamine arises. If alpha-naphthylamine flake or alpha-naphthylamine sulphate is used efficient draughting and full protective clothing will be necessary. Alpha-naphthylamine flake packs in the drum on standing so that no automatic emptying device is suitable, and for the same reason it is not suitable for pneumatic handling.
The sulphonation is never quite complete so that the naphthionic acid dust is contaminated with amine. Further, the sulphonation is preferential to the alpha-isomer so that the unsulphonated amine will contain more of the beta-isomer than the original amine charged to the sulphonator. This high proportion of beta-isomer constitutes a very real hazard. During the washing of the acid these amines are present in the liquors together with tar. This tar, contaminated with beta-naphthylamine, Equally, all residues from the plant should be handled molten in an enclosed system before disposal or destruction.
Phenyl-alpha-naphthylamine This secondary amine can be made from alphanaphthylamine but this involves charging a carcinogen to the phenylation vessel. Furthermore, the condensation with aniline is not complete and free carcinogen in the final product constitutes a hazard in isolation and its subsequent use. All these hazards can be easily eliminated by making phenylalpha-naphthylamine from alpha-naphthol. Attention should be paid to the purity of the alphanaphthol used, as this is made from alpha-naplithylamine and can contain this carcinogen as an impurity.
Phenyl-alpha-naphthylamine is not believed to be carcinogenic. Xenylamine (4-Aminodiphenyl) 4-Aminodiphenyl (referred to as xenylamine in the U.S.A.) has never been manufactured in Great Britain because experiments in rats and dogs demonstrated its carcinogenicity before its proposed manufacture (Walpole, Williams, and Roberts, 1952, 1954) . Subsequently, Melick Escue, Naryka, Mezera, and Wheeler (1955) confirmed the existence of an industrial hazard in a report of tumours in men engaged in its manufacture in the U.S.A. Its manufacture has been discontinued there and it is recommended that manufacture should not be started in Great Britain. There is also the possibility that a hazard may also have been associated with the manufacture of 4-nitrodiphenyl due to the reduction in the body of the nitro compound to the corresponding amine.
ASSESSMENT OF RESULTS ACHIEVED BY IMPROVEMENTS
It is most important to ensure that the improvements in plant and working which have been introduced are effective. It An additional check is afforded by the examination of the urine of workers for the presence of excess amines. Methods have been described by Kuchenbecker (1920) and by Glassman and Meigs (1951 It is hoped that the recommendations contained in this report will be carried out by the industry as soon as is practicable, but it must be remembered that the benefits to be reaped will not necessarily be visible for many years to come. SUMMARY Safe methods of working practice recommended to the Association of British Chemical Manufacturers for the manufacture and use of chemical compounds likely to induce tumours of the bladder are described. The present position of knowledge of industrial bladder tumours in Great Britain is given and the data from which the recommendations have been derived are detailed.
Medical supervision is essential to ensure proper control of the hazard. Desiderata for selection and education of the workers and for their personal protection are laid down. The need for maintaining accurate medical and industrial records is stressed.
Limitation of exposure and of the number of men at risk should lessen the possible incidence. The early diagnosis, treatment, and follow-up of established cases of tumour are imperative.
Design and ventilation of buildings and plant are of primary importance. Completely enclosed plant with the carcinogens totally contained in the system is the ideal. The isolation, sampling, weighing, distilling, drying, grinding, or packaging of products and the disposal of residues can all be dangerous and measures to prevent contamination of the operators are recommended. Maintenance and cleaning of buildings, plant, and plant items can lead to serious exposure and men engaged in these operations must also be protected.
Detailed consideration of the manufacture and use of each relevant compound is presented. The dangers associated with each are pointed out and specific precautionary measures are given in detail in each case.
Beta -naphthylamine a n d 4 -aminodiphenyl (xenylamine) should not be manufactured as no safe economical method can be devised. Safer alternatives which have been developed should be applied.
Benzidine should be manufactured in a closed system. The base and the salts are all dangerous and bulk handling as a slurry or as tetrazo solution is preferred in user factories.
The homologues and derivatives of benzidine are considered to be less carcinogenic than the parent amine but if large amounts are involved, they should be treated with equal care.
Alpha-naphthylamine should be manufactured in a closed system and bulk handling of molten amine in enclosed containers or tankers is the safest method for the large user.
